Data as of Mar 12
| +0.36 / +5.31%|
The 8 analysts offering 12-month price forecasts for Idenix Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 11.00 and a low estimate of 3.00. The median estimate represents a -29.97% decrease from the last price of 7.14.
The current consensus among 9 polled investment analysts is to Hold stock in Idenix Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.